(S)-3-Hydroxypyrrolidine Hydrochloride CAS 122536-94-1 Purity ≥98.0% (GC) Darifenacin Hydrobromide Intermediate

Short Description:

Chemical Name: (S)-3-Hydroxypyrrolidine Hydrochloride

CAS: 122536-94-1

Appearance: Off-White to Brown Crystalline Powder

Purity: ≥98.0% (GC)

Intermediate of Darifenacin Hydrobromide (CAS 133099-07-7) in the treatment of Overactive Bladder

Contact: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

122536-94-1 - Description:

Shanghai Ruifu Chemical is the leading supplier of (S)-3-Hydroxypyrrolidine Hydrochloride (CAS: 122536-94-1) with high quality, mainly used as an intermediate of Darifenacin Hydrobromide (CAS: 133099-07-7).
Ruifu Chemical has been supplying pharmaceutical intermediates and API (active pharmaceutical ingredient) more than 15 years, can provide worldwide delivery, competitive price, excellent service.
Purchase (S)-3-Hydroxypyrrolidine Hydrochloride or other Darifenacin Hydrobromide intermediates, please contact us by e-mail: alvin@ruifuchem.com  

Intermediates of Darifenacin Hydrobromide:

(S)-3-Hydroxypyrrolidine Hydrochloride CAS: 122536-94-1
(S)-α,α-Diphenyl-3-Pyrrolidineacetamide L-Tartrate CAS: 134002-26-9
(S)-2,2-Diphenyl-2-(Pyrrolidin-3-yl)acetonitrile Hydrobromide CAS: 194602-27-2                             
(S)-2,2-Diphenyl-2-(1-Tosylpyrrolidin-3-yl)acetonitrile CAS: 133099-09-9
2,3-Dihydrobenzofuran CAS: 496-16-2
2,3-Dihydrobenzofuranyl-5-Acetic Acid CAS: 69999-16-2
5-(2-Bromoethyl)-2,3-Dihydrobenzofuran CAS: 127264-14-6
Darifenacin Hydrobromide CAS: 133099-07-7

122536-94-1 - Chemical Properties:

Chemical Name (S)-3-Hydroxypyrrolidine Hydrochloride
Synonyms (S)-3-Hydroxypyrrolidine HCl; (S)-3-Pyrrolidinol Hydrochloride; (S)-Pyrrolidin-3-ol (Hydrochloride); (S)-Pyrrolidin-3-ol, HCl
CAS Number 122536-94-1
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C4H10ClNO
Molecular Weight 123.581
Melting Point 104.0~107.0℃
Boiling Point 108.0~110.0℃ (8mmHg)
Solubility DMSO (Sparingly), Methanol (Slightly)
Stability Hygroscopic
Storage Condition  Inert Atmosphere, Cool and Dry Place
Shipping Condition Shipped Under Ambient Temperature
Shelf Life 24 Months When Properly Stored
COA & MSDS Available
Place of Origin  Shanghai, China
Product Categories Pharmaceutical Intermediates
Brand Ruifu Chemical

122536-94-1 - Specifications:

Item Specifications Results
Appearance Off-White to Brown Crystalline Powder Pale Brown Crystalline Powder
Chemical Purity  ≥98.0% (GC) 99.6%
Specific Optical Rotation +6.5° ~ +8.5° (C=3 CH3OH) +7.6°
Melting Point 104.0~107.0℃ 106.0~107.0℃
Any Individual Impurity ≤0.50% Conforms       
Total Impurities ≤2.00% Conforms  
Loss on Drying ≤0.50% Conforms      
Infrared Spectrometry Conforms to Structure Conforms
Conclusion The product has been tested and complies with the given specifications
Usage Intermediate of Darifenacin Hydrobromide (CAS: 133099-07-7)  

122536-94-1 - Package/Storage/Shipping:

Package: Fluorinated bottle, aluminium foil bag, 25kg/cardboard drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed. Store in a cool, dry (2-8℃) and well-ventilated warehouse away from incompatible substances. Prevent direct sunlight; avoid fire and heat sources; avoid moisture.
Shipping: Deliver to worldwide by air, by sea, by FedEx / DHL Express. Provide fast and reliable delivery. 

122536-94-1 - Advantages:

Sufficient Capacity: Sufficient facilities and technicians

Professional Service: One stop purchasing service

OEM Package: Custom package and label available

Fast Delivery: If within stock, three days delivery guaranteed

Stable Supply: Maintain reasonable stock    

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

High Quality: Established a complete quality assurance system

122536-94-1 - FAQ:

How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.

Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.

Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.

Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.

Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.

Factory Audit? Factory audit welcome. Please make an appointment in advance.

MOQ? No MOQ. Small order is acceptable.

Delivery Time? If within stock, three days delivery guaranteed.

Transportation? By Express (FedEx, DHL), by Air, by Sea.

Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.

Custom Synthesis? Can provide custom synthesis services to best fit your research needs.

Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.  

122536-94-1 - Risk and Safety:

Hazard Symbols Xi - Irritant
Safety Description
S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S37 - Wear suitable gloves.
HS Code 2933990099

122536-94-1 - Application:

(S)-3-Hydroxypyrrolidine Hydrochloride (CAS: 122536-94-1) is widely used in organic synthesis, synthesis of pharmaceutical intermediates and Active Pharmaceutical Ingredient (API) synthesis.
(S)-3-Hydroxypyrrolidine Hydrochloride is the main intermediate of Darifenacin Hydrobromide (CAS: 133099-07-7).
Darifenacin Hydrobromide (CAS: 133099-07-7), an orally active, once a day selective M3 receptor antagonist, was launched for the treatment of overactive bladder in patients with symptoms of urge urinary incontinence, urgency and frequency. The drug selectively inhibits M3 receptor in the detrusor muscle while sparing the M1 and M2 receptors that are believed to be involved in central nervous system and cardiovascular function respectively. The compound was originally developed by Pfizer and licensed to Novartis and Bayer.

  • Write your message here and send it to us